Openbookopenbook
Equity
StockUS listing USSAFLYPINKHealthcareBalanced

Safilo Group SpA ADR(SAFLY) Stock Analysis | Healthcare

USD --+0.00%
Reward52Moderate
Risk54Moderate
75%Data
Thin 5% profit margin
USD —+0.00 (+0.00%) Previous close · PINK
Market cap 839.60M
Reward Ratingⓘ52 Moderate reward assessment · 75% data coverage
Bottom 50% of stocksView factors
Risk Ratingⓘ54 Moderate risk assessment
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on SAFLY to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Safilo Group SpA ADR?

engages in the design, manufacture, and distribution of optical frames, sunglasses, sports eyewear, goggles, and helmets in North America, Europe, the Asia Pacific, and internationally.

AI Brief Pro

The brief on Safilo Group SpA ADR

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is Safilo Group SpA ADR?

engages in the design, manufacture, and distribution of optical frames, sunglasses, sports eyewear, goggles, and helmets in North America, Europe, the Asia Pacific, and internationally. The company offers its products under the own brands, including Carrera, Polaroid Eyewear, Seventh Street, Smith, Blenders Eyewear, and Privé Revaux Eyewear; and licensed brands, such as BOSS, Carolina Herrera, DSQUARED2, Etro, Fossil, HUGO, Isabel Marant, David Beckham, Juicy Couture, Kate Spade New York, Levi's, Liz Claiborne, Love Moschino, Marc Jacobs, Missoni, Moschino, Pierre Cardin, PORTS, Stuart Weitzman, Tommy Hilfiger, TOMMY JEANS, and Under Armour. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 839.60M, and a P/E ratio of 15.4x.

Financial Highlights

Investment Breakdown

Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
Profitability
Adequate profitability with some margin variability in recent periods.
Risk
Risk profile appears balanced versus broad market conditions.
Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (52)

Similar stocks to compare

A short list of Medical Instruments & Supplies names that are close enough in size to make side-by-side comparison useful.

KSRBFSmall Cap / 842M market cap
Kossan Rubber Industries Bhd
Compare
GRRMYSmall Cap / 788M market cap
Gerresheimer AG
Compare
NNCSFSmall Cap / 774M market cap
Nanosonics Limited
Compare
Company Information
SectorHealthcare
IndustryMedical Instruments & Supplies
Market Cap839.60M
P/E Ratio15.3846
Dividend YieldN/A
Beta1.309
Insider Activity
12M windowNo data
No insider activity data available for this ticker.
openbook

Stock research for UK and US investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.